Loftenius A - Search Results

1

Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD Domain.

Liu Y, Vorobyeva A, Xu T, Orlova A, Loftenius A, Bengtsson T, Jonasson P, Tolmachev V, Frejd FY. Liu Y, et al. Among authors: loftenius a. Pharmaceutics. 2021 Jun 7;13(6):839. doi: 10.3390/pharmaceutics13060839. Pharmaceutics. 2021. PMID: 34200197 Free PMC article.

2

Preclinical Evaluation of ^99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake.

Oroujeni M, Rinne SS, Vorobyeva A, Loftenius A, Feldwisch J, Jonasson P, Chernov V, Orlova A, Frejd FY, Tolmachev V. Oroujeni M, et al. Among authors: loftenius a. Int J Mol Sci. 2021 Mar 9;22(5):2770. doi: 10.3390/ijms22052770. Int J Mol Sci. 2021. PMID: 33803361 Free PMC article.

3

Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule ¹⁸⁸Re-ZHER2:41071.

Liu Y, Vorobyeva A, Orlova A, Konijnenberg MW, Xu T, Bragina O, Loftenius A, Rosander E, Frejd FY, Tolmachev V. Liu Y, et al. Among authors: loftenius a. Pharmaceutics. 2022 May 20;14(5):1092. doi: 10.3390/pharmaceutics14051092. Pharmaceutics. 2022. PMID: 35631678 Free PMC article.

4

Differential regulation of in vitro cytokine production by human blood cells in response to methylmethacrylate.

Liu Y, Loftenius A, ElGhazali G, Troye-Blomberg M, Ma S, Ekstrand J. Liu Y, et al. Among authors: loftenius a. J Toxicol Environ Health A. 1999 Feb 12;56(3):165-82. doi: 10.1080/009841099158132. J Toxicol Environ Health A. 1999. PMID: 9973002

5

Fluoride augments the mitogenic and antigenic response of human blood lymphocytes in vitro.

Loftenius A, Andersson B, Butler J, Ekstrand J. Loftenius A, et al. Caries Res. 1999;33(2):148-55. doi: 10.1159/000016509. Caries Res. 1999. PMID: 9892783

6

HgCl(2)-induced human lymphocyte activation in vitro: a superantigenic mechanism?

Loftenius A, Ekstrand J, Möller E. Loftenius A, et al. Int Arch Allergy Immunol. 1999 Sep;120(1):63-70. doi: 10.1159/000024221. Int Arch Allergy Immunol. 1999. PMID: 10529590

7

In vitro effects of mercuric chloride (HgCl2) on human mononuclear cells.

Loftenius A, Ekstrand J, Möller E. Loftenius A, et al. Clin Exp Immunol. 1997 Dec;110(3):418-22. doi: 10.1046/j.1365-2249.1997.4531470.x. Clin Exp Immunol. 1997. PMID: 9409645 Free PMC article.

8

Acute exposure to mercury from amalgam: no short-time effect on the peripheral blood lymphocytes in healthy individuals.

Loftenius A, Sandborgh-Englund G, Ekstrand J. Loftenius A, et al. J Toxicol Environ Health A. 1998 Aug 7;54(7):547-60. doi: 10.1080/009841098158692. J Toxicol Environ Health A. 1998. PMID: 9726779

9

No evidence for specific in vitro lymphocyte reactivity to HgCl2 in patients with dental amalgam-related contact lesions.

Loftenius A, Skoglund A, Ekstrand J, Hovmark A, Möller E. Loftenius A, et al. J Oral Pathol Med. 1999 Sep;28(8):364-70. doi: 10.1111/j.1600-0714.1999.tb02055.x. J Oral Pathol Med. 1999. PMID: 10478962

10

Rapid communication: acute exposure to mercury from dental amalgam does not affect the levels of C-reactive protein or interleukin-6 in peripheral blood.

Sandborgh-Englund G, af Geijersstam E, Loftenius A. Sandborgh-Englund G, et al. Among authors: loftenius a. J Toxicol Environ Health A. 2003 Mar 28;66(6):495-9. doi: 10.1080/15287390306352. J Toxicol Environ Health A. 2003. PMID: 12712592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters